Supporting Patients with Serious Mental Illness

An estimated one in 20 Americans has a serious mental illness. When these patients can’t access the right treatment, it harms not only them but also their families and communities. Read One-Pager

Next Steps to Hepatitis C Elimination

For states working to eliminate hepatitis C, acquiring curative medications in bulk is a critical step. But it is only part of a comprehensive elimination strategy. Available medication won’t cure people with hepatitis C unless it’s coupled with several other important actions.

Comprehensive Treatment for Tardive Dyskinesia

Involuntary facial expressions. Difficulty eating, speaking and swallowing. Embarassment. These are common experiences of people who live with a disorder of the nervous system called tardive dyskinesia.

Huntington’s Disease: The Need for a Cure

Uncontrollable movements. Memory loss. Personality changes. Difficulty eating and drinking. These are all common experiences for patients with Huntington’s disease, making independent living and interpersonal relationships tremendously difficult.

Understanding IgG4-RD

From difficult symptoms to an accurate diagnosis to effective treatment, the rare disease journey is a long one. But despite the challenges patients face, innovation and education are regularly improving lives.

Vaccines and Preventive Monoclonal Antibodies

Vaccines and preventive monoclonal antibodies are two different types of immunization. While they function differently, they both serve the same purpose: protecting people from serious illnesses and diseases. View One-Pager

Accelerated Approval

The U.S. Food and Drug Administration’s standard approval process for new drugs delivers patients the safest, most advanced medications in the world.

Eliminating Hepatitis C in America

Hepatitis C is a paradox of American health care. The medical community has never been better equipped to diagnose, cure and prevent this potentially fatal liver disease.